{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:17:23Z","timestamp":1791919043488,"version":"4.3.4"},"reference-count":280,"publisher":"Bentham Science Publishers Ltd.","issue":"4","funder":[{"DOI":"10.13039\/501100001427","name":"All India Council for Technical Education","doi-asserted-by":"publisher","award":["8-112\/RIFD\/RPS\/NER\/Policy\/1\/2018-19"],"award-info":[{"award-number":["8-112\/RIFD\/RPS\/NER\/Policy\/1\/2018-19"]}],"id":[{"id":"10.13039\/501100001427","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["45\/10\/2018\/TM\/BMS"],"award-info":[{"award-number":["45\/10\/2018\/TM\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDDT"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Cancer-induced mortality is increasingly prevalent globally, which skyrocketed\nthe necessity to discover new\/novel, safe and effective anticancer drugs. Cancer is characterized\nby the continuous multiplication of cells in the human, which is unable to control. Scientific research\nis drawing its attention toward naturally-derived bioactive compounds as they have fewer side effects\ncompared to the current synthetic drugs used for chemotherapy.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Drugs isolated from natural sources and their role in the manipulation of epigenetic markers\nin cancer are discussed briefly in this review article.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>With advancing medicinal plant biotechnology and microbiology in the past century, several\nanticancer phytomedicines were developed. Modern pharmacopeia contains at least 25% herbal-based\nremedies, including clinically used anticancer drugs. These drugs mainly include the podophyllotoxin\nderivatives vinca alkaloids, curcumin, mistletoe plant extracts, taxanes, camptothecin, combretastatin,\nand colchicine artesunate, homoharringtonine, ellipticine, roscovitine, maytansine, tapsigargin,and\nbruceantin.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Compounds (psammaplin, didemnin, dolastin, ecteinascidin, and halichondrin) isolated from\nmarine sources and animals such as microalgae, cyanobacteria, heterotrophic bacteria, invertebrates.\nThey have been evaluated for their anticancer activity on cells and experimental animal models and\nused chemotherapy.Drug-induced manipulation of epigenetic markers plays an important role in the\ntreatment of cancer.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The development of a new drug from isolated bioactive compounds of plant sources has\nbeen a feasible way to lower the toxicity and increase their effectiveness against cancer. Potential anticancer\ntherapeutic leads obtained from various ethnomedicinal plants, foods, marine, and microorganisms\nare showing effective yet realistically safe pharmacological activity. This review will highlight\nimportant plant-based bioactive compounds like curcumin, stilbenes, terpenes, other polyphenolic\nphyto-compounds, and structurally related families that are used to prevent\/ ameliorate cancer. However,\na contribution from all possible fields of science is still a prerequisite for discovering safe and\neffective anticancer drugs.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570163819666220331095744","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T09:20:46Z","timestamp":1648804846000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Cancer Chemotherapy <i>via<\/i> Natural Bioactive Compounds"],"prefix":"10.2174","volume":"19","author":[{"given":"Kalyani","family":"Pathak","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh - 786004, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manash P.","family":"Pathak","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical\nSciences, Assam Down Town University, Panikhaiti, Guwahati-781026, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya","family":"Saikia","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh - 786004, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urvashee","family":"Gogoi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh - 786004, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon J.","family":"Sahariah","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh - 786004, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Zothantluanga","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh - 786004, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Samanta","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh - 786004, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparoop","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh - 786004, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/ijc.27711","volume":"132","author":"Bray F.","year":"2013","unstructured":"Bray F.; Ren J.S.; Masuyer E.; Ferlay J.; Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013,132(5),1133-1145","journal-title":"Int J Cancer"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"Ferlay J.","year":"2010","unstructured":"Ferlay J.; Shin H.R.; Bray F.; Forman D.; Mathers C.; Parkin D.M.; Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010,127(12),2893-2917","journal-title":"Int J Cancer"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"Ferlay J.","year":"2015","unstructured":"Ferlay J.; Soerjomataram I.; Dikshit R.; Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015,136(5),E359-E386","journal-title":"Int J Cancer"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"Bray F.","year":"2018","unstructured":"Bray F.; Ferlay J.; Soerjomataram I.; Siegel R.L.; Torre L.A.; Jemal A.; Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018,68(6),394-424","journal-title":"CA Cancer J Clin"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1093\/carcin\/bgu197","volume":"35","author":"Snellenberg S.","year":"2014","unstructured":"Snellenberg S.; Cillessen S.A.; Van Criekinge W.; Methylation-mediated repression of PRDM14 contributes to apoptosis evasion in HPV-positive cancers. Carcinogenesis 2014,35(11),2611-2618","journal-title":"Carcinogenesis"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fphar.2017.00109","volume":"8","author":"Redondo-Blanco S.","year":"2017","unstructured":"Redondo-Blanco S.; Fernandez J.; Gutierrez-del-Rio I.; Villar C.J.; Lombo F.; New insights toward colorectal cancer chemotherapy using natural bioactive compounds. Front Pharmacol 2017,8,109","journal-title":"Front Pharmacol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"770","DOI":"10.2174\/1871520616666160817111242","volume":"17","author":"Baraya Y.S.","year":"2017","unstructured":"Baraya Y.S.; Wong K.K.; Yaacob N.S.; The Immunomodulatory Potential of Selected Bioactive Plant-Based Compounds in Breast Cancer: A Review. Anticancer Agents Med Chem 2017,17(6),770-783","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12906-016-1254-2","volume":"16","author":"Reddivari L.","year":"2016","unstructured":"Reddivari L.; Charepalli V.; Radhakrishnan S.; Grape compounds suppress colon cancer stem cells in vitro and in a rodent model of colon carcinogenesis. BMC Compl Alterna Medi 2016,16,278","journal-title":"BMC Compl Alterna Medi"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"Hanahan D.","year":"2011","unstructured":"Hanahan D.; Weinberg R.A.; Hallmarks of cancer: the next generation. Cell 2011,144(5),646-674","journal-title":"Cell"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ijc.21496","volume":"118","author":"Shigematsu H.","year":"2006","unstructured":"Shigematsu H.; Gazdar A.F.; Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer 2006,118(2),257-262","journal-title":"Int J Cancer"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1158\/1078-0432.CCR-05-1692","volume":"12","author":"Leone F.","year":"2006","unstructured":"Leone F.; Cavalloni G.; Pignochino Y.; Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma. Clin Cancer Res 2006,12(6),1680-1685","journal-title":"Clin Cancer Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.1182\/blood-2007-05-090308","volume":"111","author":"Xiang Z.","year":"2008","unstructured":"Xiang Z.; Zhao Y.; Mitaksov V.; Identification of somatic JAK1 mutations in patients with acute myeloid leukemia. Blood 2008,111(9),4809-4812","journal-title":"Blood"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"8236","DOI":"10.1073\/pnas.1811263115","volume":"115","author":"Foulds C.E.","year":"2018","unstructured":"Foulds C.E.; Disrupting a negative feedback loop drives endocrine therapy-resistant breast cancer. Proc Natl Acad Sci USA 2018,115(33),8236-8238","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=14","author":"Cooper G.M.","year":"2004","unstructured":"Cooper G.M.; Hausman R.E.;  The cell: A molecular approach Available from:\n2004","journal-title":"The cell: A molecular approach"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"11520","DOI":"10.7150\/thno.44829","volume":"10","author":"Chen Z.","year":"2020","unstructured":"Chen Z.; Fan Z.; Dou X.; Inactivation of tumor suppressor gene Clusterin leads to hyperactivation of TAK1-NF-&#x3BA;B signaling axis in lung cancer cells and denotes a therapeutic opportunity. Theranostics 2020,10(25),11520-11534","journal-title":"Theranostics"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu9070728","volume":"9","author":"Li Y.","year":"2017","unstructured":"Li Y.; Li S.; Meng X.; Gan R.Y.; Zhang J.J.; Li H.B.; Dietary Natural Products for Prevention and Treatment of Breast Cancer. Nutrients 2017,9(7),1-38","journal-title":"Nutrients"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"819","DOI":"10.21873\/invivo.11313","volume":"32","author":"Strunk M.A.","year":"2018","unstructured":"Strunk M.A.; Zopf E.M.; Steck J.; Hamacher S.; Hallek M.; Baumann F.T.; Effects of kyusho jitsu on physical activity-levels and quality of life in breast cancer patients. In Vivo 2018,32(4),819-824","journal-title":"In Vivo"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"Jemal A.","year":"2011","unstructured":"Jemal A.; Bray F.; Center M.M.; Ferlay J.; Ward E.; Forman D.; Global cancer statistics. CA Cancer J Clin 2011,61(2),69-90","journal-title":"CA Cancer J Clin"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"Siegel R.L.","year":"2018","unstructured":"Siegel R.L.; Miller K.D.; Jemal A.; Cancer statistics, 2018. CA Cancer J Clin 2018,68(1),7-30","journal-title":"CA Cancer J Clin"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1158\/1055-9965.EPI-15-0293","volume":"24","author":"Chen L.","year":"2015","unstructured":"Chen L.; Li C.I.; Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status. Cancer Epidemiol Biomarkers Prev 2015,24(11),1666-1672","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.15430\/JCP.2015.20.4.223","volume":"20","author":"Ko E.Y.","year":"2015","unstructured":"Ko E.Y.; Moon A.; Natural products for chemoprevention of breast cancer. J Cancer Prev 2015,20(4),223-231","journal-title":"J Cancer Prev"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines6030073","volume":"6","author":"Kamaruzman N.I.","year":"2018","unstructured":"Kamaruzman N.I.; Tiash S.; Ashaie M.; Chowdhury E.H.; siRNAs targeting growth factor receptor and anti-apoptotic genes synergistically kill breast cancer cells through inhibition of MAPK and PI-3 kinase pathways. Biomedicines 2018,6(3),1-17","journal-title":"Biomedicines"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"6205","DOI":"10.2147\/IJN.S140325","volume":"12","author":"Singh S.K.","year":"2017","unstructured":"Singh S.K.; Singh S.; Lillard J.W.; Singh R.; Drug delivery approaches for breast cancer. Int J Nanomedicine 2017,12,6205-6218","journal-title":"Int J Nanomedicine"},{"key":"ref=24","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8324696","volume":"2018","author":"Mitra S.","year":"2018","unstructured":"Mitra S.; Dash R.; Natural products for the management and prevention of breast cancer. Evid Based Complement Alternat Med 2018,2018","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.biopha.2018.04.113","volume":"103","author":"Ijaz S.","year":"2018","unstructured":"Ijaz S.; Akhtar N.; Khan M.S.; Plant derived anticancer agents: A green approach towards skin cancers. Biomed Pharmacother 2018,103,1643-1651","journal-title":"Biomed Pharmacother"},{"key":"ref=26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18030656","volume":"18","author":"Aung T.N.","year":"2017","unstructured":"Aung T.N.; Qu Z.; Kortschak R.D.; Adelson D.L.; Understanding the effectiveness of natural compound mixtures in cancer through their molecular mode of action. Int J Mol Sci 2017,18(3)","journal-title":"Int J Mol Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.bbrc.2018.04.174","volume":"500","author":"Aghapour F.","year":"2018","unstructured":"Aghapour F.; Moghadamnia A.A.; Nicolini A.; Quercetin conjugated with silica nanoparticles inhibits tumor growth in MCF-7 breast cancer cell lines. Biochem Biophys Res Commun 2018,500(4),860-865","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/mc.21839","volume":"52","author":"Li J.","year":"2013","unstructured":"Li J.; Zhu F.; Lubet R.A.; Quercetin-3-methyl ether inhibits lapatinib-sensitive and -resistant breast cancer cell growth by inducing G(2)\/M arrest and apoptosis. Mol Carcinog 2013,52(2),134-143","journal-title":"Mol Carcinog"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/0973-7847.194044","volume":"10","author":"Anand David A.V.","year":"2016","unstructured":"Anand David A.V.; Arulmoli R.; Parasuraman S.; Overviews of biological importance of quercetin: A bioactive flavonoid. Pharmacogn Rev 2016,10(20),84-89","journal-title":"Pharmacogn Rev"},{"key":"ref=30","doi-asserted-by":"publisher","DOI":"10.1177\/1178223417749855","volume":"12","author":"Manouchehri J.M.","year":"2018","unstructured":"Manouchehri J.M.; Turner K.A.; Kalafatis M.; TRAIL-induced apoptosis in TRAIL-resistant breast carcinoma through quercetin cotreatment. Breast Cancer (Auckl) 2018,12","journal-title":"Breast Cancer (Auckl)"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.2147\/IJN.S153094","volume":"13","author":"Patra A.","year":"2018","unstructured":"Patra A.; Satpathy S.; Shenoy A.K.; Bush J.A.; Kazi M.; Hussain M.D.; Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers. Int J Nanomedicine 2018,13,2869-2881","journal-title":"Int J Nanomedicine"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.12659\/MSM.908022","volume":"24","author":"Wang R.","year":"2018","unstructured":"Wang R.; Yang L.; Li S.; Quercetin inhibits breast cancer stem cells via downregulation of aldehyde dehydrogenase 1A1 (ALDH1A1), chemokine receptor type 4 (CXCR4), Mucin 1 (MUC1), and epithelial cell adhesion molecule (EpCAM). Med Sci Monit 2018,24,412-420","journal-title":"Med Sci Monit"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.ejmech.2017.11.007","volume":"143","author":"Lan J.","year":"2018","unstructured":"Lan J.; Huang L.; Lou H.; Design and synthesis of novel C14-urea-tetrandrine derivatives with potent anti-cancer activity. Eur J Med Chem 2018,143,1968-1980","journal-title":"Eur J Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.3390\/cancers3022274","volume":"3","author":"Xu W.","year":"2011","unstructured":"Xu W.; Debeb B.G.; Lacerda L.; Li J.; Woodward W.A.; Tetrandrine, a compound common in chinese traditional medicine, preferentially kills breast cancer tumor initiating cells (TICs) in vitro. Cancers (Basel) 2011,3(2),2274-2285","journal-title":"Cancers (Basel)"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1021\/acs.molpharmaceut.7b00381","volume":"14","author":"Jiang M.","year":"2017","unstructured":"Jiang M.; Zhang R.; Wang Y.; Reduction-sensitive paclitaxel prodrug self-assembled nanoparticles with tetrandrine effectively promote synergistic therapy against drug-sensitive and multidrug-resistant breast cancer. Mol Pharm 2017,14(11),3628-3635","journal-title":"Mol Pharm"},{"key":"ref=36","first-page":"488","volume":"33","author":"Chen H.Y.","year":"2013","unstructured":"Chen H.Y.; Chen X.Y.; Tetrandrine reversed the resistance of tamoxifen in human breast cancer MCF-7\/TAM cells: an experimental research. Zhongguo Zhong Xi Yi Jie He Za Zhi 2013,33(4),488-491","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3389\/fphar.2017.00351","volume":"8","author":"Wong V.K.W.","year":"2017","unstructured":"Wong V.K.W.; Zeng W.; Chen J.; Tetrandrine, an activator of autophagy, induces autophagic cell death via PKC-&#x3B1;  inhibition and mTOR-dependent mechanisms. Front Pharmacol 2017,8,351","journal-title":"Front Pharmacol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.phymed.2010.10.013","volume":"18","author":"Kim H.Y.","year":"2011","unstructured":"Kim H.Y.; Choi T.W.; Kim H.J.; A methylene chloride fraction of Saururus chinensis induces apoptosis through the activation of caspase-3 in prostate and breast cancer cells. Phytomedicine 2011,18(7),567-574","journal-title":"Phytomedicine"},{"key":"ref=39","first-page":"813","author":"Chung B.S.","year":"1990","unstructured":"Chung B.S.; Shin M.G.;  Dictionary of Korean folk medicine 1990,813-814","journal-title":"Dictionary of Korean folk medicine"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.intimp.2010.06.001","volume":"10","author":"Bae H.B.","year":"2010","unstructured":"Bae H.B.; Li M.; Son J.K.; Sauchinone, a lignan from Saururus chinensis, reduces tumor necrosis factor-alpha production through the inhibition of c-raf\/MEK1\/2\/ERK 1\/2 pathway activation. Int Immunopharmacol 2010,10(9),1022-1028","journal-title":"Int Immunopharmacol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1742-4658.2009.07366.x","volume":"277","author":"Cagnol S.","year":"2010","unstructured":"Cagnol S.; Chambard J.C.; ERK and cell death: mechanisms of ERK-induced cell death--apoptosis, autophagy and senescence. FEBS J 2010,277(1),2-21","journal-title":"FEBS J"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clon.2006.11.013","volume":"19","author":"Esc&#xE1;rcega R.O.","year":"2007","unstructured":"Esc&#xE1;rcega R.O.; Fuentes-Alexandro S.; Garc&#xED;a-Carrasco M.; Gatica A.; Zamora A.; The transcription factor nuclear factor-kappa B and cancer. Clin Oncol 2007,19(2),154-161","journal-title":"Clin Oncol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1055\/s-2003-45189","volume":"69","author":"Hwang B.Y.","year":"2003","unstructured":"Hwang B.Y.; Lee J.H.; Jung H.S.; Sauchinone, a lignan from Saururus chinensis, suppresses iNOS expression through the inhibition of transactivation activity of RelA of NF-kappaB. Planta Med 2003,69(12),1096-1101","journal-title":"Planta Med"},{"key":"ref=44","first-page":"567","volume":"27","author":"Kim E.S.","year":"2012","unstructured":"Kim E.S.; Jeong C.S.; Moon A.; Genipin, a constituent of Gardenia jasminoides Ellis, induces apoptosis and inhibits invasion in MDA-MB-231 breast cancer cells. Oncol Rep 2012,27(2),567-572","journal-title":"Oncol Rep"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1471-4159.2010.06903.x","volume":"115","author":"Koriyama Y.","year":"2010","unstructured":"Koriyama Y.; Chiba K.; Yamazaki M.; Suzuki H.; Muramoto K.; Kato S.; Long-acting genipin derivative protects retinal ganglion cells from oxidative stress models in vitro and in vivo through the Nrf2\/antioxidant response element signaling pathway. J Neurochem 2010,115(1),79-91","journal-title":"J Neurochem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1254\/jphs.12234FP","volume":"121","author":"Yang X.","year":"2013","unstructured":"Yang X.; Yao J.; Luo Y.; Han Y.; Wang Z.; Du L.; P38 MAP kinase mediates apoptosis after genipin treatment in non-small-cell lung cancer H1299 cells via a mitochondrial apoptotic cascade. J Pharmacol Sci 2013,121(4),272-281","journal-title":"J Pharmacol Sci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.biomaterials.2015.01.007","volume":"51","author":"Bhattacharya S.","year":"2015","unstructured":"Bhattacharya S.; Ahir M.; Patra P.; PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a. Biomaterials 2015,51,91-107","journal-title":"Biomaterials"},{"key":"ref=48","first-page":"539","volume":"14","author":"Dehghani H.","year":"2015","unstructured":"Dehghani H.; Hashemi M.; Entezari M.; Mohsenifar A.; The comparison of anticancer activity of thymoquinone and nanothymoquinone on human breast adenocarcinoma. Iran J Pharm Res 2015,14(2),539-546","journal-title":"Iran J Pharm Res"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3892\/ijmm.2013.1563","volume":"33","author":"Motaghed M.","year":"2014","unstructured":"Motaghed M.; Al-Hassan F.M.; Hamid S.S.; Thymoquinone regulates gene expression levels in the estrogen metabolic and interferon pathways in MCF7 breast cancer cells. Int J Mol Med 2014,33(1),8-16","journal-title":"Int J Mol Med"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3109\/10717544.2012.727500","volume":"19","author":"Odeh F.","year":"2012","unstructured":"Odeh F.; Ismail S.I.; Abu-Dahab R.; Mahmoud I.S.; Al Bawab A.; Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer. Drug Deliv 2012,19(8),371-377","journal-title":"Drug Deliv"},{"key":"ref=51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075356","volume":"8","author":"Woo C.C.","year":"2013","unstructured":"Woo C.C.; Hsu A.; Kumar A.P.; Sethi G.; Tan K.H.; Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: the role of p38 MAPK and ROS. PLoS One 2013,8(10)","journal-title":"PLoS One"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4103\/0974-8490.112428","volume":"5","author":"Motaghed M.","year":"2013","unstructured":"Motaghed M.; Al-Hassan F.M.; Hamid S.S.; Cellular responses with thymoquinone treatment in human breast cancer cell line MCF-7. Pharmacognosy Res 2013,5(3),200-206","journal-title":"Pharmacognosy Res"},{"key":"ref=53","unstructured":"World Health Organization. GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide. 2001.Available\nfrom: \n[23.03.2021]"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"51907","DOI":"10.18632\/oncotarget.17206","volume":"8","author":"Asaduzzaman Khan M.","year":"2017","unstructured":"Asaduzzaman Khan M.; Tania M.; Fu S.; Fu J.; Thymoquinone, as an anticancer molecule: from basic research to clinical investigation. Oncotarget 2017,8(31),51907-51919","journal-title":"Oncotarget"},{"key":"ref=55","first-page":"2730","volume":"60","author":"Strassheim D.","year":"2000","unstructured":"Strassheim D.; Shafer S.H.; Phelps S.H.; Williams C.L.; Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma. Cancer Res 2000,60(10),2730-2736","journal-title":"Cancer Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/thorax.57.1.20","volume":"57","author":"Clegg A.","year":"2002","unstructured":"Clegg A.; Scott D.A.; Hewitson P.; Sidhu M.; Waugh N.; Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review. Thorax 2002,57(1),20-28","journal-title":"Thorax"},{"key":"ref=57","first-page":"61","volume":"1","author":"Toyooka S.","year":"2001","unstructured":"Toyooka S.; Toyooka K.O.; Maruyama R.; DNA methylation profiles of lung tumors. Mol Cancer Ther 2001,1(1),61-67","journal-title":"Mol Cancer Ther"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"4608","DOI":"10.1073\/pnas.072077299","volume":"99","author":"Chan D.","year":"2002","unstructured":"Chan D.; Gera L.; Stewart J.; Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a &#x201C;biased agonist&#x201D; mechanism. Proc Natl Acad Sci USA 2002,99(7),4608-4613","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=59","first-page":"1798","volume":"7","author":"Young L.C.","year":"2001","unstructured":"Young L.C.; Campling B.G.; Cole S.P.C.; Deeley R.G.; Gerlach J.H.; Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels. Clin Cancer Res 2001,7(6),1798-1804","journal-title":"Clin Cancer Res"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/jnci\/91.14.1194","volume":"91","author":"Hecht S.S.","year":"1999","unstructured":"Hecht S.S.; Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999,91(14),1194-1210","journal-title":"J Natl Cancer Inst"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"21S","DOI":"10.1378\/chest.123.1_suppl.21S","volume":"123","author":"Alberg A.J.","year":"2003","unstructured":"Alberg A.J.; Samet J.M.; Epidemiology of lung cancer. Chest 2003,123(1)(Suppl.),21S-49S","journal-title":"Chest"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1055\/s-2003-37718","volume":"69","author":"Tang W.","year":"2003","unstructured":"Tang W.; Hemm I.; Bertram B.; Recent development of antitumor agents from chinese herbal medicines; part I. Low molecular compounds. Planta Med 2003,69(2),97-108","journal-title":"Planta Med"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1054\/bjoc.2001.2142","volume":"85","author":"Barthelmes H.U.","year":"2001","unstructured":"Barthelmes H.U.; Niederberger E.; Roth T.; Lycobetaine acts as a selective topoisomerase II beta poison and inhibits the growth of human tumour cells. Br J Cancer 2001,85(10),1585-1591","journal-title":"Br J Cancer"},{"key":"ref=64","year":"2004","unstructured":"Cancer Facts  American Cancer SocietyAvailable from: \n[24.03.2021]2004","journal-title":"Cancer Facts"},{"key":"ref=65","first-page":"703","volume":"28","author":"Wang P.","year":"1996","unstructured":"Wang P.; Shi G.B.; Song G.Q.; Chen K.X.; Ji R.Y.; Assignment of proton resonances and conformational characterization of oligodeoxyribonucleic acid d (CCGTACGG) in solution. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 1996,28(6),703-705","journal-title":"Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao"},{"key":"ref=66","first-page":"437","volume":"10","author":"Liu J.","year":"1989","unstructured":"Liu J.; Yang S.L.; Xu B.; Characteristics of the interaction of lycobetaine with DNA. Chung Kuo Yao Li Hsueh Pao 1989,10(5),437-442","journal-title":"Chung Kuo Yao Li Hsueh Pao"},{"key":"ref=67","first-page":"1191","volume":"9","author":"Eckardt J.","year":"1995","unstructured":"Eckardt J.; Eckhardt G.; Villalona-Calero M.; Drengler R.; Von Hoff D.; New anticancer agents in clinical development. Oncology (Williston Park) 1995,9(11),1191-1199","journal-title":"Oncology (Williston Park)"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1211\/0022357001777270","volume":"52","author":"Kimura Y.","year":"2000","unstructured":"Kimura Y.; Okuda H.; Effects of naturally occurring stilbene glucosides from medicinal plants and wine, on tumour growth and lung metastasis in Lewis lung carcinoma-bearing mice. J Pharm Pharmacol 2000,52(10),1287-1295","journal-title":"J Pharm Pharmacol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/carcin\/22.8.1111","volume":"22","author":"Gusman J.","year":"2001","unstructured":"Gusman J.; Malonne H.; Atassi G.; A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis 2001,22(8),1111-1117","journal-title":"Carcinogenesis"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1093\/jn\/131.6.1844","volume":"131","author":"Kimura Y.","year":"2001","unstructured":"Kimura Y.; Okuda H.; Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 2001,131(6),1844-1849","journal-title":"J Nutr"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1634\/theoncologist.5-3-185","volume":"5","author":"Mans D.R.","year":"2000","unstructured":"Mans D.R.; da Rocha A.B.; Schwartsmann G.; Anti-cancer drug discovery and development in Brazil: targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds. Oncologist 2000,5(3),185-198","journal-title":"Oncologist"},{"key":"ref=72","first-page":"1794","volume":"53","author":"Rowinsky E.K.","year":"1993","unstructured":"Rowinsky E.K.; Noe D.A.; Ettinger D.S.; Phase I and pharmacological study of the pulmonary cytotoxin 4-ipomeanol on a single dose schedule in lung cancer patients: hepatotoxicity is dose limiting in humans. Cancer Res 1993,53(8),1794-1801","journal-title":"Cancer Res"},{"key":"ref=73","first-page":"3484","volume":"46","author":"Falzon M.","year":"1986","unstructured":"Falzon M.; McMahon J.B.; Schuller H.M.; Boyd M.R.; Metabolic activation and cytotoxicity of 4-ipomeanol in human non-small cell lung cancer lines. Cancer Res 1986,46(7),3484-3489","journal-title":"Cancer Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/15287398909531305","volume":"27","author":"Trela B.A.","year":"1989","unstructured":"Trela B.A.; Carlson G.P.; Turek J.; Rebar A.; Mathews J.M.; Effect of carbon monoxide on the cytochrome P-450-mediated activation of 4-ipomeanol by the isolated perfused rabbit lung. J Toxicol Environ Health 1989,27(3),341-350","journal-title":"J Toxicol Environ Health"},{"key":"ref=75","first-page":"687","volume":"207","author":"Boyd M.R.","year":"1978","unstructured":"Boyd M.R.; Burka L.T.; In vivo studies on the relationship between target organ alkylation and the pulmonary toxicity of a chemically reactive metabolite of 4-ipomeanol. J Pharmacol Exp Ther 1978,207(3),687-697","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=76","first-page":"15","volume":"4","author":"Alexandrova R.","year":"2000","unstructured":"Alexandrova R.; Alexandrov I.; Velcheva M.; Varadinova T.; Phytoproducts and cancer. Exp Pathol Parasitol 2000,4,15-26","journal-title":"Exp Pathol Parasitol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF00685333","volume":"33","author":"Wilkoff L.J.","year":"1993","unstructured":"Wilkoff L.J.; Dulmadge E.A.; Vasanthakumar G.; Donahue J.P.; Etoposide-resistant human colon and lung adenocarcinoma cell lines exhibit sensitivity to homoharringtonine. Cancer Chemother Pharmacol 1993,33(2),149-153","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00210-002-0632-0","volume":"367","author":"Efferth T.","year":"2003","unstructured":"Efferth T.; Sauerbrey A.; Halatsch M.E.; Ross D.D.; Gebhart E.; Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines. Naunyn Schmiedebergs Arch Pharmacol 2003,367(1),56-67","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=79","doi-asserted-by":"publisher","author":"Roth MT","unstructured":"Roth MT; Cardin DB; Berlin JD;  Recent advances in the treatment of pancreatic cancer. F1000Res 2020; 9 F1000 Faculty Rev-13.","DOI":"10.12688\/f1000research.21981.1"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"Mizrahi J.D.","year":"2020","unstructured":"Mizrahi J.D.; Surana R.; Valle J.W.; Shroff R.T.; Pancreatic cancer. Lancet 2020,395(10242),2008-2020","journal-title":"Lancet"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.7314\/APJCP.2015.16.14.5619","volume":"16","author":"Goral V.","year":"2015","unstructured":"Goral V.; Pancreatic Cancer: Pathogenesis and Diagnosis. Asian Pac J Cancer Prev 2015,16(14),5619-5624","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.canlet.2016.07.022","volume":"381","author":"Midha S.","year":"2016","unstructured":"Midha S.; Chawla S.; Garg P.K.; Modifiable and non-modifiable risk factors for pancreatic cancer: A review. Cancer Lett 2016,381(1),269-277","journal-title":"Cancer Lett"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","volume":"378","author":"Vincent A.","year":"2011","unstructured":"Vincent A.; Herman J.; Schulick R.; Hruban R.H.; Goggins M.; Pancreatic cancer. Lancet 2011,378(9791),607-620","journal-title":"Lancet"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1055\/s-0043-123472","volume":"84","author":"R&#xED;os J.L.","year":"2018","unstructured":"R&#xED;os J.L.; M&#xE1;&#xF1;ez S.; New Pharmacological Opportunities for Betulinic Acid. Planta Med 2018,84(1),8-19","journal-title":"Planta Med"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1007\/s00253-020-10495-1","volume":"104","author":"An T.","year":"2020","unstructured":"An T.; Zha W.; Zi J.; Biotechnological production of betulinic acid and derivatives and their applications. Appl Microbiol Biotechnol 2020,104(8),3339-3348","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1021\/je200531k","volume":"56","author":"Cheng Y.","year":"2011","unstructured":"Cheng Y.; Shao Y.; Yan W.; Solubilities of betulinic acid in thirteen organic solvents at different temperatures. J Chem Eng Data 2011,56(12),4587-4591","journal-title":"J Chem Eng Data"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"6713","DOI":"10.1016\/j.bmc.2006.05.075","volume":"14","author":"Gauthier C.","year":"2006","unstructured":"Gauthier C.; Legault J.; Lebrun M.; Dufour P.; Pichette A.; Glycosidation of lupane-type triterpenoids as potent in vitro cytotoxic agents. Bioorg Med Chem 2006,14(19),6713-6725","journal-title":"Bioorg Med Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molmed.2004.11.001","volume":"11","author":"Aiken C.","year":"2005","unstructured":"Aiken C.; Chen C.H.; Betulinic acid derivatives as HIV-1 antivirals. Trends Mol Med 2005,11(1),31-36","journal-title":"Trends Mol Med"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10637-007-9081-4","volume":"26","author":"Rajendran P.","year":"2008","unstructured":"Rajendran P.; Jaggi M.; Singh M.K.; Mukherjee R.; Burman A.C.; Pharmacological evaluation of C-3 modified Betulinic acid derivatives with potent anticancer activity. Invest New Drugs 2008,26(1),25-34","journal-title":"Invest New Drugs"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1021\/acs.jafc.5b06021","volume":"64","author":"Silva F.S.","year":"2016","unstructured":"Silva F.S.; Oliveira P.J.; Duarte M.F.; Oleanolic, ursolic, and betulinic acids as food supplements or pharmaceutical agents for type 2 diabetes: promise or illusion? J Agric Food Chem 2016,64(15),2991-3008","journal-title":"J Agric Food Chem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/ptr.3672","volume":"26","author":"Kim J.","year":"2012","unstructured":"Kim J.; Lee Y.S.; Kim C.S.; Kim J.S.; Betulinic acid has an inhibitory effect on pancreatic lipase and induces adipocyte lipolysis. Phytother Res 2012,26(7),1103-1106","journal-title":"Phytother Res"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/med.20156","volume":"29","author":"Gautam R.","year":"2009","unstructured":"Gautam R.; Jachak S.M.; Recent developments in anti-inflammatory natural products. Med Res Rev 2009,29(5),767-820","journal-title":"Med Res Rev"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4236\/pp.2012.32018","volume":"3","author":"Moghaddam M.G.","year":"2012","unstructured":"Moghaddam M.G.; Ahmad J.B.H.; Samzadeh-Kermani A.; Biological activity of betulinic acid: a review. Pharmacol Pharm 2012,3,119-123","journal-title":"Pharmacol Pharm"},{"key":"ref=94","first-page":"1777","volume":"17","author":"Waechter F.","year":"2017","unstructured":"Waechter F.; da Silva G.N.S.; Willig J.B.; Design, synthesis and biological evaluation of betulinic acid derivatives as new antitumor agents for leukemia. Anticancer Agents Med Chem 2017,17(13),1777-1785","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107154","volume":"9","author":"Pandita A.","year":"2014","unstructured":"Pandita A.; Kumar B.; Manvati S.; Vaishnavi S.; Singh S.K.; Bamezai R.N.; Synergistic combination of gemcitabine and dietary molecule induces apoptosis in pancreatic cancer cells and down regulates PKM2 expression. PLoS One 2014,9(9)","journal-title":"PLoS One"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cbi.2015.03.018","volume":"233","author":"Pandita A.","year":"2015","unstructured":"Pandita A.; Manvati S.; Singh S.K.; Vaishnavi S.; Bamezai R.N.; Combined effect of microRNA, nutraceuticals and drug on pancreatic cancer cell lines. Chem Biol Interact 2015,233,56-64","journal-title":"Chem Biol Interact"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"9420","DOI":"10.1016\/j.bmc.2008.09.053","volume":"16","author":"Arai M.A.","year":"2008","unstructured":"Arai M.A.; Tateno C.; Hosoya T.; Koyano T.; Kowithayakorn T.; Ishibashi M.; Hedgehog\/GLI-mediated transcriptional inhibitors from Zizyphus cambodiana. Bioorg Med Chem 2008,16(21),9420-9424","journal-title":"Bioorg Med Chem"},{"key":"ref=98","first-page":"3056","volume":"35","author":"Jiang M.","year":"2010","unstructured":"Jiang M.; Zhou Y.; Yang M.; Influence of betulinic acid on proliferation, migration, cell cycle and apoptosis of pancreatic cancer cells. Zhongguo Zhongyao Zazhi 2010,35(22),3056-3059","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.3390\/ijms19103234","volume":"19","author":"Kutkowska J.","year":"2018","unstructured":"Kutkowska J.; Strzadala L.; Rapak A.; Sorafenib in combination with betulinic acid synergistically induces cell cycle arrest and inhibits clonogenic activity in pancreatic ductal adenocarcinoma cells. Int J Mol Sci 2018,19(10),3234","journal-title":"Int J Mol Sci"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"5182","DOI":"10.1158\/0008-5472.CAN-10-2016","volume":"71","author":"Gao Y.","year":"2011","unstructured":"Gao Y.; Jia Z.; Kong X.; Combining betulinic acid and mithramycin a effectively suppresses pancreatic cancer by inhibiting proliferation, invasion, and angiogenesis. Cancer Res 2011,71(15),5182-5193","journal-title":"Cancer Res"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1093\/carcin\/bgm189","volume":"28","author":"Chintharlapalli S.","year":"2007","unstructured":"Chintharlapalli S.; Papineni S.; Liu S.; 2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells. Carcinogenesis 2007,28(11),2337-2346","journal-title":"Carcinogenesis"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1158\/1078-0432.CCR-12-3630","volume":"19","author":"Li L.","year":"2013","unstructured":"Li L.; Du Y.; Kong X.; Lamin B1 is a novel therapeutic target of betulinic acid in pancreatic cancer. Clin Cancer Res 2013,19(17),4651-4661","journal-title":"Clin Cancer Res"},{"key":"ref=103","first-page":"98","volume":"54","author":"Sun L.","year":"2019","unstructured":"Sun L.; Cao J.; Chen K.; Betulinic acid inhibits stemness and EMT of pancreatic cancer cells via activation of AMPK signaling. Int J Oncol 2019,54(1),98-110","journal-title":"Int J Oncol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1756-8722-2-38","volume":"2","author":"Padhye S.","year":"2009","unstructured":"Padhye S.; Ahmad A.; Oswal N.; Sarkar F.H.; Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs. J Hematol Oncol 2009,2,38","journal-title":"J Hematol Oncol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/0040-4039(81)80154-2","volume":"22","author":"Krishnamurthy N.","year":"1981","unstructured":"Krishnamurthy N.; Lewis Y.S.; Ravindranath B.; On the structures of garcinol, isogarcinol and camboginol. Tetrahedron Lett 1981,22(8),793-796","journal-title":"Tetrahedron Lett"},{"key":"ref=106","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.201900366","volume":"16","author":"Schobert R.","year":"2019","unstructured":"Schobert R.; Biersack B.; Chemical and biological aspects of garcinol and isogarcinol: Recent developments. Chem Biodivers 2019,16(9)","journal-title":"Chem Biodivers"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.3390\/molecules25194513","volume":"25","author":"Espirito Santo B.L.S.D.","year":"2020","unstructured":"Espirito Santo B.L.S.D.; Santana L.F.; Kato Junior W.H.; Medicinal potential of garcinia species and their compounds. Molecules 2020,25(19),4513","journal-title":"Molecules"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/10942910802626754","volume":"13","author":"Nayak C.A.","year":"2010","unstructured":"Nayak C.A.; Rastogi N.K.; Raghavarao K.S.M.S.; Bioactive constituents present in Garcinia indica Choisy and its potential food applications: A review. Int J Food Prop 2010,13(3),441-453","journal-title":"Int J Food Prop"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/biomedicines8050103","volume":"8","author":"Aggarwal V.","year":"2020","unstructured":"Aggarwal V.; Tuli H.S.; Kaur J.; Garcinol exhibits anti-neoplastic effects by targeting diverse oncogenic factors in tumor cells. Biomedicines 2020,8(5),103","journal-title":"Biomedicines"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1021\/jf990908c","volume":"48","author":"Yamaguchi F.","year":"2000","unstructured":"Yamaguchi F.; Saito M.; Ariga T.; Yoshimura Y.; Nakazawa H.; Free radical scavenging activity and antiulcer activity of garcinol from Garcinia indica fruit rind. J Agric Food Chem 2000,48(6),2320-2325","journal-title":"J Agric Food Chem"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/carcin\/bgi208","volume":"27","author":"Hong J.","year":"2006","unstructured":"Hong J.; Sang S.; Park H.J.; Modulation of arachidonic acid metabolism and nitric oxide synthesis by garcinol and its derivatives. Carcinogenesis 2006,27(2),278-286","journal-title":"Carcinogenesis"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.freeradbiomed.2007.01.016","volume":"42","author":"Hong J.","year":"2007","unstructured":"Hong J.; Kwon S.J.; Sang S.; Effects of garcinol and its derivatives on intestinal cell growth: Inhibitory effects and autoxidation-dependent growth-stimulatory effects. Free Radic Biol Med 2007,42(8),1211-1221","journal-title":"Free Radic Biol Med"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1248\/bpb.19.311","volume":"19","author":"Iinuma M.","year":"1996","unstructured":"Iinuma M.; Tosa H.; Tanaka T.; Antibacterial activity of some Garcinia benzophenone derivatives against methicillin-resistant Staphylococcus aureus. Biol Pharm Bull 1996,19(2),311-314","journal-title":"Biol Pharm Bull"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"33716","DOI":"10.1074\/jbc.M402839200","volume":"279","author":"Balasubramanyam K.","year":"2004","unstructured":"Balasubramanyam K.; Altaf M.; Varier R.A.; Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J Biol Chem 2004,279(32),33716-33726","journal-title":"J Biol Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"5818","DOI":"10.1016\/j.bmcl.2010.07.128","volume":"20","author":"Padhye S.","year":"2010","unstructured":"Padhye S.; Ahmad A.; Oswal N.; Fluorinated 2\u2032-hydroxychalcones as garcinol analogs with enhanced antioxidant and anticancer activities. Bioorg Med Chem Lett 2010,20(19),5818-5821","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/01635581.2011.535962","volume":"63","author":"Parasramka M.A.","year":"2011","unstructured":"Parasramka M.A.; Gupta S.V.; Garcinol inhibits cell proliferation and promotes apoptosis in pancreatic adenocarcinoma cells. Nutr Cancer 2011,63(3),456-465","journal-title":"Nutr Cancer"},{"key":"ref=117","first-page":"1483","volume":"3","author":"Ahmad A.","year":"2011","unstructured":"Ahmad A.; Wang Z.; Wojewoda C.; Garcinol-induced apoptosis in prostate and pancreatic cancer cells is mediated by NF- kappaB signaling. Front Biosci (Elite Ed) 2011,3,1483-1492","journal-title":"Front Biosci (Elite Ed)"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1021\/jf001129v","volume":"49","author":"Pan M.H.","year":"2001","unstructured":"Pan M.H.; Chang W.L.; Lin-Shiau S.Y.; Ho C.T.; Lin J.K.; Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. J Agric Food Chem 2001,49(3),1464-1474","journal-title":"J Agric Food Chem"},{"key":"ref=119","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/709739","volume":"2012","author":"Parasramka M.A.","year":"2012","unstructured":"Parasramka M.A.; Gupta S.V.; Synergistic effect of garcinol and curcumin on antiproliferative and apoptotic activity in pancreatic cancer cells. J Oncol [Erratum in: J Oncol 2019; 2019: 74692842012,2012","journal-title":"J Oncol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mnfr.201200297","volume":"57","author":"Parasramka M.A.","year":"2013","unstructured":"Parasramka M.A.; Ali S.; Banerjee S.; Deryavoush T.; Sarkar F.H.; Gupta S.; Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures. Mol Nutr Food Res 2013,57(2),235-248","journal-title":"Mol Nutr Food Res"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/bab.1446","volume":"64","author":"Huang C.C.","year":"2017","unstructured":"Huang C.C.; Lin C.M.; Huang Y.J.; Garcinol downregulates Notch1 signaling via modulating miR-200c and suppresses oncogenic properties of PANC-1 cancer stem-like cells. Biotechnol Appl Biochem 2017,64(2),165-173","journal-title":"Biotechnol Appl Biochem"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1080\/01635581.2018.1502327","volume":"70","author":"Saadat N.","year":"2018","unstructured":"Saadat N.; Akhtar S.; Goja A.; Dietary garcinol arrests pancreatic cancer in p53 and K-ras conditional mutant mouse model. Nutr Cancer 2018,70(7),1075-1087","journal-title":"Nutr Cancer"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1055\/a-0797-3657","volume":"69","author":"Jaiswal N.","year":"2019","unstructured":"Jaiswal N.; Akhtar J.; Singh S.P.; Ahsan F.; Badruddeen. An overview on genistein and its various formulations. Drug Res (Stuttg) 2019,69(6),305-313","journal-title":"Drug Res (Stuttg)"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0031-9422(02)00116-4","volume":"60","author":"Dixon R.A.","year":"2002","unstructured":"Dixon R.A.; Ferreira D.; Genistein. Phytochemistry 2002,60(3),205-211","journal-title":"Phytochemistry"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.biopha.2015.10.026","volume":"76","author":"Ganai A.A.","year":"2015","unstructured":"Ganai A.A.; Farooqi H.; Bioactivity of genistein: A review of in vitro and in vivo studies. Biomed Pharmacother 2015,76,30-38","journal-title":"Biomed Pharmacother"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"5286","DOI":"10.1021\/je100261w","volume":"55","author":"Wu J.G.","year":"2010","unstructured":"Wu J.G.; Ge J.; Zhang Y.P.; Yu Y.; Zhang X.Y.; Solubility of genistein in water, methanol, ethanol, propan-2-ol, 1-butanol, and ethyl acetate from (280 to 333) K. J Chem Eng Data 2010,55(11),5286-5288","journal-title":"J Chem Eng Data"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/10715769709097785","volume":"26","author":"Ruiz-Larrea M.B.","year":"1997","unstructured":"Ruiz-Larrea M.B.; Mohan A.R.; Paganga G.; Miller N.J.; Bolwell G.P.; Rice-Evans C.A.; Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res 1997,26(1),63-70","journal-title":"Free Radic Res"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"7616","DOI":"10.1073\/pnas.102650199","volume":"99","author":"Yellayi S.","year":"2002","unstructured":"Yellayi S.; Naaz A.; Szewczykowski M.A.; The phytoestrogen genistein induces thymic and immune changes: a human health concern? Proc Natl Acad Sci USA 2002,99(11),7616-7621","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/1471-2407-11-219","volume":"11","author":"Qi W.","year":"2011","unstructured":"Qi W.; Weber C.R.; Wasland K.; Savkovic S.D.; Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer 2011,11,219","journal-title":"BMC Cancer"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00041433-200108000-00010","volume":"12","author":"Vitolins M.Z.","year":"2001","unstructured":"Vitolins M.Z.; Anthony M.; Burke G.L.; Soy protein isoflavones, lipids and arterial disease. Curr Opin Lipidol 2001,12(4),433-437","journal-title":"Curr Opin Lipidol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/sj.bjp.0702973","volume":"128","author":"Deodato B.","year":"1999","unstructured":"Deodato B.; Altavilla D.; Squadrito G.; Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury. Br J Pharmacol 1999,128(8),1683-1690","journal-title":"Br J Pharmacol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2174\/1871520615666150520142437","volume":"15","author":"Xiong P.","year":"2015","unstructured":"Xiong P.; Wang R.; Zhang X.; Design, synthesis, and evaluation of genistein analogues as anti-cancer agents. Anticancer Agents Med Chem 2015,15(9),1197-1203","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00006676-200101000-00001","volume":"22","author":"Boros L.G.","year":"2001","unstructured":"Boros L.G.; Bassilian S.; Lim S.; Lee W.N.; Genistein inhibits nonoxidative ribose synthesis in MIA pancreatic adenocarcinoma cells: a new mechanism of controlling tumor growth. Pancreas 2001,22(1),1-7","journal-title":"Pancreas"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.phymed.2017.12.001","volume":"39","author":"Bi Y.L.","year":"2018","unstructured":"Bi Y.L.; Min M.; Shen W.; Liu Y.; Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G0\/G1cell cycle arrest and regulation of STAT3 signalling pathway. Phytomedicine 2018,39,10-16","journal-title":"Phytomedicine"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00006676-200408000-00002","volume":"29","author":"Bai J.","year":"2004","unstructured":"Bai J.; Sata N.; Nagai H.; Genistein-induced changes in gene expression in Panc 1 cells at physiological concentrations of genistein. Pancreas 2004,29(2),93-98","journal-title":"Pancreas"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.2174\/138945012804545597","volume":"13","author":"Xia J.","year":"2012","unstructured":"Xia J.; Duan Q.; Ahmad A.; Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. Curr Drug Targets 2012,13(14),1750-1756","journal-title":"Curr Drug Targets"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.2174\/13894501113149990187","volume":"14","author":"Ma J.","year":"2013","unstructured":"Ma J.; Cheng L.; Liu H.; Genistein down-regulates miR-223 expression in pancreatic cancer cells. Curr Drug Targets 2013,14(10),1150-1156","journal-title":"Curr Drug Targets"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/metabo2020303","volume":"2","author":"Dias D.A.","year":"2012","unstructured":"Dias D.A.; Urban S.; Roessner U.; A historical overview of natural products in drug discovery. Metabolites 2012,2(2),303-336","journal-title":"Metabolites"},{"key":"ref=139","first-page":"2032","volume":"125","author":"Han L.","year":"2012","unstructured":"Han L.; Zhang H.W.; Zhou W.P.; Chen G.M.; Guo K.J.; The effects of genistein on transforming growth factor-&#x3B2;1-induced invasion and metastasis in human pancreatic cancer cell line Panc-1 in vitro. Chin Med J (Engl) 2012,125(11),2032-2040","journal-title":"Chin Med J (Engl)"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/cncr.11873","volume":"100","author":"B&#xFC;chler P.","year":"2004","unstructured":"B&#xFC;chler P.; Reber H.A.; B&#xFC;chler M.W.; Friess H.; Lavey R.S.; Hines O.J.; Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression. Cancer 2004,100(1),201-210","journal-title":"Cancer"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"9064","DOI":"10.1158\/0008-5472.CAN-05-1330","volume":"65","author":"Banerjee S.","year":"2005","unstructured":"Banerjee S.; Zhang Y.; Ali S.; Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res 2005,65(19),9064-9072","journal-title":"Cancer Res"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00006676-200407000-00055","volume":"29","author":"Nozawa F.","year":"2004","unstructured":"Nozawa F.; Itami A.; Saruc M.; The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL\/Apo2L) and Genistein is effective in inhibiting pancreatic cancer growth. Pancreas 2004,29(1),45-52","journal-title":"Pancreas"},{"key":"ref=143","first-page":"4685","volume":"34","author":"Suzuki R.","year":"2014","unstructured":"Suzuki R.; Kang Y.; Li X.; Roife D.; Zhang R.; Fleming J.B.; Genistein potentiates the antitumor effect of 5-Fluorouracil by inducing apoptosis and autophagy in human pancreatic cancer cells. Anticancer Res 2014,34(9),4685-4692","journal-title":"Anticancer Res"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.critrevonc.2010.01.010","volume":"74","author":"Labianca R.","year":"2010","unstructured":"Labianca R.; Beretta G.D.; Kildani B.; Colon cancer. Crit Rev Oncol Hematol 2010,74(2),106-133","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1177\/030089160709300405","volume":"93","author":"Grande E.","year":"2007","unstructured":"Grande E.; Inghelmann R.; Francisci S.; Regional estimates of colorectal cancer burden in Italy. Tumori 2007,93(4),352-359","journal-title":"Tumori"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1186\/s12885-018-4786-7","volume":"18","author":"White A.","year":"2018","unstructured":"White A.; Ironmonger L.; Steele R.J.C.; Ormiston-Smith N.; Crawford C.; Seims A.; A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK. BMC Cancer 2018,18(1),906","journal-title":"BMC Cancer"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1089\/jwh.2011.2992","volume":"21","author":"Abotchie P.N.","year":"2012","unstructured":"Abotchie P.N.; Vernon S.W.; Du X.L.; Gender differences in colorectal cancer incidence in the United States, 1975-2006. J Womens Health (Larchmt) 2012,21(4),393-400","journal-title":"J Womens Health (Larchmt)"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3322\/caac.21601","volume":"70","author":"Siegel R.L.","year":"2020","unstructured":"Siegel R.L.; Miller K.D.; Goding Sauer A.; Colorectal cancer statistics, 2020. CA Cancer J Clin 2020,70(3),145-164","journal-title":"CA Cancer J Clin"},{"key":"ref=149","first-page":"725","volume":"10","author":"Giovannucci E.","year":"2001","unstructured":"Giovannucci E.; An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001,10(7),725-731","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40139-020-00218-6","volume":"9","author":"Hmar E.B.L.","year":"2021","unstructured":"Hmar E.B.L.; Paul S.; Boruah N.; Sarkar P.; Borah S.; Sharma H.K.; Apprehending ulcerative colitis management with springing up therapeutic approaches: Can nanotechnology play a nascent role? Curr Pathobiol Rep 2021,9,9-32","journal-title":"Curr Pathobiol Rep"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1080\/01635581.2015.1087042","volume":"67","author":"Bin Sayeed M.S.","year":"2015","unstructured":"Bin Sayeed M.S.; Ameen S.S.; Beta-sitosterol: A promising but orphan nutraceutical to fight against cancer. Nutr Cancer 2015,67(8),1214-1220","journal-title":"Nutr Cancer"},{"key":"ref=152","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110702","volume":"131","author":"Babu S.","year":"2020","unstructured":"Babu S.; Jayaraman S.; An update on &#x3B2;-sitosterol: A potential herbal nutraceutical for diabetic management. Biomed Pharmacother 2020,131","journal-title":"Biomed Pharmacother"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/0003-9861(53)90478-0","volume":"47","author":"Ma R.M.","year":"1953","unstructured":"Ma R.M.; Schaffer P.S.; Beta-Sitosteryl D-glucoside and beta-sitosterol from commercially dried grapefruit pulp. Arch Biochem Biophys 1953,47(2),419-423","journal-title":"Arch Biochem Biophys"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/pharmaceutics12040386","volume":"12","author":"Soleimanian Y","year":"2020","unstructured":"Soleimanian Y; Goli SAH; Varshosaz J; &#x3B2;-Sitosterol loaded  nanostructured lipid carrier: Physical and oxidative stability, in vitro  simulated digestion and hypocholesterolemic activity. Pharmaceutics 2020,12(4),386","journal-title":"Pharmaceutics"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1021\/je9009909","volume":"55","author":"Wei D","year":"2010","unstructured":"Wei D; Wang L; Liu C; Wang B.; &#x3B2;-Sitosterol solubility in selected organic solvents. J Chem Eng Data 2010,55(8),2917-2919","journal-title":"J Chem Eng Data"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1186\/s40064-016-2894-x","volume":"5","author":"Ododo M.M.","year":"2016","unstructured":"Ododo M.M.; Choudhury M.K.; Dekebo A.H.; Structure elucidation of &#x3B2;-sitosterol with antibacterial activity from the root bark of Malva parviflora. Springerplus 2016,5(1),1210","journal-title":"Springerplus"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1080\/15376516.2018.1545815","volume":"29","author":"Ponnulakshmi R.","year":"2019","unstructured":"Ponnulakshmi R.; Shyamaladevi B.; Vijayalakshmi P.; Selvaraj J.; In silico and in vivo analysis to identify the antidiabetic activity of beta sitosterol in adipose tissue of high fat diet and sucrose induced type-2 diabetic experimental rats. Toxicol Mech Methods 2019,29(4),276-290","journal-title":"Toxicol Mech Methods"},{"key":"ref=158","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173004","volume":"873","author":"Babu S.","year":"2020","unstructured":"Babu S.; Krishnan M.; Rajagopal P.; Beta-sitosterol attenuates insulin resistance in adipose tissue via IRS-1\/Akt mediated insulin signaling in high fat diet and sucrose induced type-2 diabetic rats. Eur J Pharmacol 2020,873","journal-title":"Eur J Pharmacol"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"19779","DOI":"10.1038\/s41598-019-56320-2","volume":"9","author":"Abdou E.M.","year":"2019","unstructured":"Abdou E.M.; Fayed M.A.A.; Helal D.; Ahmed K.A.; Assessment of the hepatoprotective effect of developed lipid-polymer hybrid nanoparticles (LPHNPs) encapsulating naturally extracted &#x3B2;-Sitosterol against CCl4 induced hepatotoxicity in rats. Sci Rep 2019,9(1),19779","journal-title":"Sci Rep"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12944-019-1096-2","volume":"18","author":"Yuan C.","year":"2019","unstructured":"Yuan C.; Zhang X.; Long X.; Jin J.; Jin R.; Effect of &#x3B2;-sitosterol self-microemulsion and &#x3B2;-sitosterol ester with linoleic acid on lipid-lowering in hyperlipidemic mice. Lipids Health Dis 2019,18(1),157","journal-title":"Lipids Health Dis"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"123","DOI":"10.21010\/ajtcam.v14i1.13","volume":"14","author":"Paniagua-P&#xE9;rez R.","year":"2016","unstructured":"Paniagua-P&#xE9;rez R.; Flores-Mondrag&#xF3;n G.; Reyes-Legorreta C.; Evaluation of the anti-inflammatory capacity of beta-sitosterol in rodent assays. Afr J Tradit Complement Altern Med 2016,14(1),123-130","journal-title":"Afr J Tradit Complement Altern Med"},{"key":"ref=162","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/0973-1296.203975","volume":"13","author":"Sharmila R.","year":"2017","unstructured":"Sharmila R.; Sindhu G.; Evaluate the antigenotoxicity and anticancer role of &#x3B2;-Sitosterol by determining oxidative DNA damage and the expression of phosphorylated mitogen-activated protein kinases\u2019, C-fos, C-jun, and endothelial growth factor receptor. Pharmacogn Mag 2017,13(49),95-101","journal-title":"Pharmacogn Mag"},{"key":"ref=163","volume":"6","author":"Dighe S.","year":"2016","unstructured":"Dighe S.; Kuchekar B.; Wankhede S.; Analgesic and anti-inflammatory activity of &#x3B2;-sitosterol isolated from leaves of Oxalis corniculata. Int J Clin Pharmacol Res 2016,6(3)","journal-title":"Int J Clin Pharmacol Res"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.lfs.2005.05.078","volume":"78","author":"L&#xF3;pez-Rubalcava C.","year":"2006","unstructured":"L&#xF3;pez-Rubalcava C.; Pi&#xF1;a-Medina B.; Estrada-Reyes R.; Heinze G.; Mart&#xED;nez-V&#xE1;zquez M.; Anxiolytic-like actions of the hexane extract from leaves of Annona cherimolia in two anxiety paradigms: possible involvement of the GABA\/benzodiazepine receptor complex. Life Sci 2006,78(7),730-737","journal-title":"Life Sci"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"566","DOI":"10.4103\/1735-5362.272565","volume":"14","author":"Abbas M.M.","year":"2019","unstructured":"Abbas M.M.; Al-Rawi N.; Abbas M.A.; Al-Khateeb I.; Naringenin potentiated &#x3B2;-sitosterol healing effect on the scratch wound assay. Res Pharm Sci 2019,14(6),566-573","journal-title":"Res Pharm Sci"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.intimp.2012.04.017","volume":"13","author":"Fraile L.","year":"2012","unstructured":"Fraile L.; Crisci E.; C&#xF3;rdoba L.; Navarro M.A.; Osada J.; Montoya M.; Immunomodulatory properties of beta-sitosterol in pig immune responses. Int Immunopharmacol 2012,13(3),316-321","journal-title":"Int Immunopharmacol"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"9789","DOI":"10.1021\/acs.jafc.9b02730","volume":"67","author":"Park Y.J.","year":"2019","unstructured":"Park Y.J.; Bang I.J.; Jeong M.H.; Effects of &#x3B2;-Sitosterol from corn silk on TGF-&#x3B2;1-Induced epithelial\u2013Mesenchymal transition in lung alveolar epithelial cells. J Agric Food Chem 2019,67(35),9789-9795","journal-title":"J Agric Food Chem"},{"key":"ref=168","first-page":"2797","volume":"16","author":"Awad A.B.","year":"1996","unstructured":"Awad A.B.; Chen Y.C.; Fink C.S.; Hennessey T.; beta-Sitosterol inhibits HT-29 human colon cancer cell growth and alters membrane lipids. Anticancer Res 1996,16(5A),2797-2804","journal-title":"Anticancer Res"},{"key":"ref=169","first-page":"471","volume":"18","author":"Awad A.B.","year":"1998","unstructured":"Awad A.B.; von Holtz R.L.; Cone J.P.; Fink C.S.; Chen Y.C.; beta-Sitosterol inhibits growth of HT-29 human colon cancer cells by activating the sphingomyelin cycle. Anticancer Res 1998,18(1A),471-473","journal-title":"Anticancer Res"},{"key":"ref=170","first-page":"1657","volume":"23","author":"Choi Y.H.","year":"2003","unstructured":"Choi Y.H.; Kong K.R.; Kim Y.A.; Induction of Bax and activation of caspases during beta-sitosterol-mediated apoptosis in human colon cancer cells. Int J Oncol 2003,23(6),1657-1662","journal-title":"Int J Oncol"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1472-6882-10-24","volume":"10","author":"Baskar A.A.","year":"2010","unstructured":"Baskar A.A.; Ignacimuthu S.; Paulraj G.M.; Al Numair K.S.; Chemopreventive potential of beta-Sitosterol in experimental colon cancer model--an in vitro and In vivo study. BMC Complement Altern Med 2010,10,24","journal-title":"BMC Complement Altern Med"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1089\/jmf.2011.1780","volume":"15","author":"Baskar AA","year":"2012","unstructured":"Baskar AA; Al Numair KS; Gabriel Paulraj M; Alsaif MA; Muamar MA; Ignacimuthu S;  J Med Food  &#x3B2;-sitosterol prevents lipid peroxidation and improves antioxidant status and histoarchitecture in rats with 1,2-dimethylhydrazine-induced colon cancer. 2012,15(4),335-343","journal-title":"J Med Food"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1021\/acs.jafc.0c00107","volume":"68","author":"Wang Z","year":"2020","unstructured":"Wang Z; Zhan Y; Xu J;  J Agric Food Chem &#x3B2;-sitosterol reverses multidrug resistance via BCRP suppression by inhibiting the p53-MDM2 interaction in colorectal cancer.2020,68(12),3850-3858","journal-title":"J Agric Food Chem"},{"key":"ref=174","first-page":"42","volume":"13","author":"Shathviha PC","year":"2021","unstructured":"Shathviha PC; Ezhilarasan D; Rajeshkumar S; Selvaraj J;  Avicenna J Med Biotechnol &#x3B2;- sitosterol mediated silver nanoparticles induce cytotoxicity in human colon cancer HT-29 cells. 2021,13(1),42-46","journal-title":"Avicenna J Med Biotechnol"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"7198","DOI":"10.1021\/acs.jafc.5b01639","volume":"63","author":"Li H.","year":"2015","unstructured":"Li H.; Ji H.S.; Kang J.H.; Soy leaf extract containing kaempferol glycosides and pheophorbides improves glucose homeostasis by enhancing pancreatic &#x3B2;-cell function and suppressing hepatic lipid accumulation in db\/db Mice. J Agric Food Chem 2015,63(32),7198-7210","journal-title":"J Agric Food Chem"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejmech.2014.08.011","volume":"86","author":"Rajendran P.","year":"2014","unstructured":"Rajendran P.; Rengarajan T.; Nandakumar N.; Palaniswami R.; Nishigaki Y.; Nishigaki I.; Kaempferol, a potential cytostatic and cure for inflammatory disorders. Eur J Med Chem 2014,86,103-112","journal-title":"Eur J Med Chem"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3390\/molecules23071751","volume":"23","author":"Sharifi-Rad M.","year":"2018","unstructured":"Sharifi-Rad M.; Fokou P.V.T.; Sharopov F.; Antiulcer agents: From plant extracts to phytochemicals in healing promotion. Molecules 2018,23(7),1751","journal-title":"Molecules"},{"key":"ref=178","doi-asserted-by":"publisher","DOI":"10.1088\/1742-6596\/1349\/1\/012003","volume":"1349","author":"Idris S.A.","year":"2019","unstructured":"Idris S.A.; Markom M.; Rahman N.A.; Ali J.M.; Quantitative HPLC analysis of flavonoids in three different solvent extracts in leaves of Gynura procumbens. J Phys Conf Ser 2019,1349","journal-title":"J Phys Conf Ser"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.3390\/molecules24122277","volume":"24","author":"Imran M.","year":"2019","unstructured":"Imran M.; Salehi B.; Sharifi-Rad J.; Kaempferol: A key emphasis to its anticancer potential. Molecules 2019,24(12),2277","journal-title":"Molecules"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00204-007-0215-4","volume":"81","author":"Kampk&#xF6;tter A.","year":"2007","unstructured":"Kampk&#xF6;tter A.; Gombitang Nkwonkam C.; Zurawski R.F.; Effects of the flavonoids kaempferol and fisetin on thermotolerance, oxidative stress and FoxO transcription factor DAF-16 in the model organism Caenorhabditis elegans. Arch Toxicol 2007,81(12),849-858","journal-title":"Arch Toxicol"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jep.2009.04.024","volume":"124","author":"De Melo G.O.","year":"2009","unstructured":"De Melo G.O.; Malvar Ddo C.; Vanderlinde F.A.; Antinociceptive and anti-inflammatory kaempferol glycosides from Sedum dendroideum. J Ethnopharmacol 2009,124(2),228-232","journal-title":"J Ethnopharmacol"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1080\/01635580802666281","volume":"61","author":"Luo H.","year":"2009","unstructured":"Luo H.; Rankin G.O.; Liu L.; Daddysman M.K.; Jiang B.H.; Chen Y.C.; Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells. Nutr Cancer 2009,61(4),554-563","journal-title":"Nutr Cancer"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s005350170147","volume":"36","author":"Kataoka M.","year":"2001","unstructured":"Kataoka M.; Hirata K.; Kunikata T.; Antibacterial action of tryptanthrin and kaempferol, isolated from the indigo plant (Polygonum tinctorium Lour.), against Helicobacter pylori-infected Mongolian gerbils. J Gastroenterol 2001,36(1),5-9","journal-title":"J Gastroenterol"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1055\/s-2000-8550","volume":"66","author":"Mitrocotsa D.","year":"2000","unstructured":"Mitrocotsa D.; Mitaku S.; Axarlis S.; Harvala C.; Malamas M.; Evaluation of the antiviral activity of kaempferol and its glycosides against human cytomegalovirus. Planta Med 2000,66(4),377-379","journal-title":"Planta Med"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/0140-6736(93)92876-U","volume":"342","author":"Hertog M.G.","year":"1993","unstructured":"Hertog M.G.; Feskens E.J.; Hollman P.C.; Katan M.B.; Kromhout D.; Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993,342(8878),1007-1011","journal-title":"Lancet"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1093\/ajcn\/75.5.880","volume":"75","author":"Geleijnse J.M.","year":"2002","unstructured":"Geleijnse J.M.; Launer L.J.; Van der Kuip D.A.; Hofman A.; Witteman J.C.; Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr 2002,75(5),880-886","journal-title":"Am J Clin Nutr"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1093\/aje\/kwm016","volume":"165","author":"Lin J.","year":"2007","unstructured":"Lin J.; Rexrode K.M.; Hu F.; Dietary intakes of flavonols and flavones and coronary heart disease in US women. Am J Epidemiol 2007,165(11),1305-1313","journal-title":"Am J Epidemiol"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10408690490263756","volume":"44","author":"Hannum S.M.","year":"2004","unstructured":"Hannum S.M.; Potential impact of strawberries on human health: a review of the science. Crit Rev Food Sci Nutr 2004,44(1),1-17","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1248\/bpb.29.2510","volume":"29","author":"Yu S.F.","year":"2006","unstructured":"Yu S.F.; Shun C.T.; Chen T.M.; Chen Y.H.; 3-O-beta-D-glucosyl-(1-->6)-beta-D-glucosyl-kaempferol isolated from Sauropus androgenus reduces body weight gain in Wistar rats. Biol Pharm Bull 2006,29(12),2510-2513","journal-title":"Biol Pharm Bull"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1021\/np030513u","volume":"67","author":"de Sousa E.","year":"2004","unstructured":"de Sousa E.; Zanatta L.; Seifriz I.; Hypoglycemic effect and antioxidant potential of kaempferol-3,7-O-(alpha)-dirhamnoside from Bauhinia forficata leaves. J Nat Prod 2004,67(5),829-832","journal-title":"J Nat Prod"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/carcin\/bgi003","volume":"26","author":"Nakamura Y.","year":"2005","unstructured":"Nakamura Y.; Chang C.C.; Mori T.; Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cells. Carcinogenesis 2005,26(3),665-671","journal-title":"Carcinogenesis"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cbi.2008.10.048","volume":"177","author":"Li W.","year":"2009","unstructured":"Li W.; Du B.; Wang T.; Wang S.; Zhang J.; Kaempferol induces apoptosis in human HCT116 colon cancer cells via the Ataxia-Telangiectasia Mutated-p53 pathway with the involvement of p53 Upregulated Modulator of Apoptosis. Chem Biol Interact 2009,177(2),121-127","journal-title":"Chem Biol Interact"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejphar.2010.11.034","volume":"654","author":"Nirmala P.","year":"2011","unstructured":"Nirmala P.; Ramanathan M.; Effect of kaempferol on lipid peroxidation and antioxidant status in 1,2-dimethyl hydrazine induced colorectal carcinoma in rats. Eur J Pharmacol 2011,654(1),75-79","journal-title":"Eur J Pharmacol"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.3390\/ijms15022722","volume":"15","author":"Lee H.S.","year":"2014","unstructured":"Lee H.S.; Cho H.J.; Yu R.; Lee K.W.; Chun H.S.; Park J.H.; Mechanisms underlying apoptosis-inducing effects of Kaempferol in HT-29 human colon cancer cells. Int J Mol Sci 2014,15(2),2722-2737","journal-title":"Int J Mol Sci"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3892\/mmr.2019.10296","volume":"20","author":"Li Q.","year":"2019","unstructured":"Li Q.; Wei L.; Lin S.; Chen Y.; Lin J.; Peng J.; Synergistic effect of kaempferol and 5 fluorouracil on the growth of colorectal cancer cells by regulating the PI3K\/Akt signaling pathway. Mol Med Rep 2019,20(1),728-734","journal-title":"Mol Med Rep"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41598-018-36808-z","volume":"9","author":"Riahi-Chebbi I.","year":"2019","unstructured":"Riahi-Chebbi I.; Souid S.; Othman H.; The Phenolic compound Kaempferol overcomes 5-fluorouracil resistance in human resistant LS174 colon cancer cells. Sci Rep 2019,9(1),195","journal-title":"Sci Rep"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"9960","DOI":"10.1021\/acs.jafc.8b02656","volume":"66","author":"Choi J.B.","year":"2018","unstructured":"Choi J.B.; Kim J.H.; Lee H.; Pak J.N.; Shim B.S.; Kim S.H.; Reactive oxygen species and p53 mediated activation of p38 and caspases is critically involved in kaempferol induced apoptosis in colorectal cancer cells. J Agric Food Chem 2018,66(38),9960-9967","journal-title":"J Agric Food Chem"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1089\/jmf.2019.0059","volume":"23","author":"Gutierrez-Uribe J.A.","year":"2020","unstructured":"Gutierrez-Uribe J.A.; Salinas-Santander M.; Serna-Guerrero D.; Serna-Saldivar S.R.O.; Rivas-Estilla A.M.; Rios-Ibarra C.P.; Inhibition of miR31 and miR92a as oncological biomarkers in RKO colon cancer cells treated with kaempferol-3-O-glycoside isolated from black bean. J Med Food 2020,23(1),50-55","journal-title":"J Med Food"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/ptr.5694","volume":"30","author":"Lu L.","year":"2016","unstructured":"Lu L.; Guo Q.; Zhao L.; Overview of oroxylin A: A promising flavonoid compound. Phytother Res 2016,30(11),1765-1774","journal-title":"Phytother Res"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/jama.1990.03450030111043","volume":"264","author":"Osofsky H.J.","year":"1990","unstructured":"Osofsky H.J.; Efficacious treatments of PMS: a need for further research. JAMA 1990,264(3),387","journal-title":"JAMA"},{"key":"ref=201","first-page":"79","volume":"31","author":"Gao Y.","year":"2009","unstructured":"Gao Y.; Process on anti-cancer effects of oroxylin A. Fujian Med J 2009,31(3),79-81","journal-title":"Fujian Med J"},{"key":"ref=202","first-page":"2512","volume":"39","author":"Guo Y.","year":"2012","unstructured":"Guo Y.; Qu J.; Zhao Y.; Wang H.; Progress in research of the natural product oroxylin A. Liaoning J Trad Chin Med 2012,39(12),2512-2515","journal-title":"Liaoning J Trad Chin Med"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ijpharm.2017.06.068","volume":"528","author":"Yu H.","year":"2017","unstructured":"Yu H.; Chang J.S.; Kim S.Y.; Kim Y.G.; Choi H.K.; Enhancement of solubility and dissolution rate of baicalein, wogonin and oroxylin A extracted from Radix scutellariae. Int J Pharm 2017,528(1-2),602-610","journal-title":"Int J Pharm"},{"key":"ref=204","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/408187","volume":"2012","author":"Liu C.H.","year":"2012","unstructured":"Liu C.H.; Chen M.F.; Tseng T.L.; Chen L.G.; Kuo J.S.; Lee T.J.; Oroxylin a, but not vasopressin, ameliorates cardiac dysfunction of endotoxemic rats. Evid Based Complement Alternat Med 2012,2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.bbrc.2006.10.064","volume":"351","author":"Hu Y.","year":"2006","unstructured":"Hu Y.; Yang Y.; You Q.D.; Oroxylin A induced apoptosis of human hepatocellular carcinoma cell line HepG2 was involved in its antitumor activity. Biochem Biophys Res Commun 2006,351(2),521-527","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1139\/bcb-2014-0030","volume":"92","author":"Ye M.","year":"2014","unstructured":"Ye M.; Wang Q.; Zhang W.; Li Z.; Wang Y.; Hu R.; Oroxylin A exerts anti-inflammatory activity on lipopolysaccharide-induced mouse macrophage via Nrf2\/ARE activation. Biochem Cell Biol 2014,92(5),337-348","journal-title":"Biochem Cell Biol"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.neures.2010.11.008","volume":"69","author":"Jeon S.J.","year":"2011","unstructured":"Jeon S.J.; Rhee S.Y.; Seo J.E.; Oroxylin A increases BDNF production by activation of MAPK-CREB pathway in rat primary cortical neuronal culture. Neurosci Res 2011,69(3),214-222","journal-title":"Neurosci Res"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s12272-013-0233-0","volume":"37","author":"Ku S.K.","year":"2014","unstructured":"Ku S.K.; Lee I.C.; Bae J.S.; Antithrombotic activities of oroxylin Ain vitro and in vivo. Arch Pharm Res 2014,37(5),679-686","journal-title":"Arch Pharm Res"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.phymed.2014.08.014","volume":"21","author":"Singh J.","year":"2014","unstructured":"Singh J.; Kakkar P.; Oroxylin A, a constituent of Oroxylum indicum inhibits adipogenesis and induces apoptosis in 3T3-L1 cells. Phytomedicine 2014,21(12),1733-1741","journal-title":"Phytomedicine"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1097\/MIB.0b013e318293c5e0","volume":"19","author":"Yang X.","year":"2013","unstructured":"Yang X.; Zhang F.; Wang Y.; Oroxylin A inhibits colitis-associated carcinogenesis through modulating the IL-6\/STAT3 signaling pathway. Inflamm Bowel Dis 2013,19(9),1990-2000","journal-title":"Inflamm Bowel Dis"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/CAD.0b013e3283512703","volume":"23","author":"Hu R.","year":"2012","unstructured":"Hu R.; Chen N.; Yao J.; The role of Nrf2 and apoptotic signaling pathways in oroxylin A-mediated responses in HCT-116 colorectal adenocarcinoma cells and xenograft tumors. Anticancer Drugs 2012,23(6),651-658","journal-title":"Anticancer Drugs"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/jcp.24833","volume":"230","author":"Qiao C.","year":"2015","unstructured":"Qiao C.; Wei L.; Dai Q.; UCP2-related mitochondrial pathway participates in oroxylin A-induced apoptosis in human colon cancer cells. J Cell Physiol 2015,230(5),1054-1063","journal-title":"J Cell Physiol"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.18632\/oncotarget.7927","volume":"7","author":"Qiao C.","year":"2016","unstructured":"Qiao C.; Lu N.; Zhou Y.; Oroxylin A modulates mitochondrial function and apoptosis in human colon cancer cells by inducing mitochondrial translocation of wild-type p53. Oncotarget 2016,7(13),17009-17020","journal-title":"Oncotarget"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1139\/o2012-005","volume":"90","author":"Ha J.","year":"2012","unstructured":"Ha J.; Zhao L.; Zhao Q.; Oroxylin A improves the sensitivity of HT-29 human colon cancer cells to 5-FU through modulation of the COX-2 signaling pathway. Biochem Cell Biol 2012,90(4),521-531","journal-title":"Biochem Cell Biol"},{"key":"ref=215","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.261","volume":"8","author":"Ni T.","year":"2017","unstructured":"Ni T.; He Z.; Dai Y.; Yao J.; Guo Q.; Wei L.; Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1","journal-title":"Cell Death Dis"},{"key":"ref=216","first-page":"577","volume":"11","author":"Etemadi A.","year":"2008","unstructured":"Etemadi A.; Sadjadi A.; Semnani S.; Nouraie S.M.; Khademi H.; Bahadori M.; Cancer registry in Iran: a brief overview. Arch Iran Med 2008,11(5),577-580","journal-title":"Arch Iran Med"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.3390\/nu11071483","volume":"11","author":"Salehi B.","year":"2019","unstructured":"Salehi B.; Valere P.; Fokou T.; Phytochemicals in prostate cancer","journal-title":"Nutrients"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.bbamcr.2016.02.016","volume":"1863","author":"Packer J.R.","year":"2016","unstructured":"Packer J.R.; Maitland N.J.; The molecular and cellular origin of human prostate cancer. Biochim Biophys Acta 2016,1863(6 Pt A),1238-1260","journal-title":"Biochim Biophys Acta"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2337\/dc10-0666","volume":"33","author":"Giovannucci E.","year":"2010","unstructured":"Giovannucci E.; Harlan D.M.; Archer M.C.; Diabetes and cancer: a consensus report. Diabetes Care 2010,33(7),1674-1685","journal-title":"Diabetes Care"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1002\/ijc.29408","volume":"137","author":"Jahn J.L.","year":"2015","unstructured":"Jahn J.L.; Giovannucci E.L.; Stampfer M.J.; The high prevalence of undiagnosed prostate cancer at autopsy: Implications for epidemiology and treatment of prostate cancer in the prostate-specific antigen-Era. Int J Cancer 2015,137(12),2795-2802","journal-title":"Int J Cancer"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s11095-008-9574-7","volume":"25","author":"Barve A.","year":"2008","unstructured":"Barve A.; Khor T.O.; Hao X.; Murine prostate cancer inhibition by dietary phytochemicals - Curcumin and phenyethylisothiocyanate. Pharm Res 2008,25(9),2181-2189","journal-title":"Pharm Res"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-3-319-41342-6_8","volume":"929","author":"Mohd Yusof Y.A.","year":"2016","unstructured":"Mohd Yusof Y.A.; Gingerol and its role in chronic diseases. Adv Exp Med Biol 2016,929,177-207","journal-title":"Adv Exp Med Biol"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/mnfr.201600025","volume":"60","author":"Lall R.K.","year":"2016","unstructured":"Lall R.K.; Adhami V.M.; Mukhtar H.; Dietary flavonoid fisetin for cancer prevention and treatment. Mol Nutr Food Res 2016,60(6),1396-1405","journal-title":"Mol Nutr Food Res"},{"key":"ref=224","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108612","volume":"112","author":"Imran M.","year":"2019","unstructured":"Imran M.; Rauf A.; Abu-Izneid T.; Luteolin, a flavonoid, as an anticancer agent: A review. Biomed Pharmacother 2019,112","journal-title":"Biomed Pharmacother"},{"key":"ref=225","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2015.09.002","author":"Nabavi SF","unstructured":"Nabavi SF; Braidy N; Gortzi O;  Luteolin as an anti-inflammatory and neuroprotective agent: A brief review . Brain Res Bull 2015; 119(Pt A): 1-11.","journal-title":"Luteolin as an anti-inflammatory and neuroprotective agent: A brief review"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s11427-013-4568-z","volume":"58","author":"Yao J.","year":"2015","unstructured":"Yao J.; Kong W.; Jiang J.; Learning from berberine: Treating chronic diseases through multiple targets. Sci China Life Sci 2015,58(9),854-859","journal-title":"Sci China Life Sci"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1080\/15384047.2016.1210728","volume":"17","author":"Zhang R.","year":"2016","unstructured":"Zhang R.; Qiao H.; Chen S.; Berberine reverses lapatinib resistance of HER2-positive breast cancer cells by increasing the level of ROS. Cancer Biol Ther 2016,17(9),925-934","journal-title":"Cancer Biol Ther"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/ptr.5693","volume":"30","author":"Imenshahidi M.","year":"2016","unstructured":"Imenshahidi M.; Hosseinzadeh H.; Berberis vulgaris and berberine: An update review. Phytother Res 2016,30(11),1745-1764","journal-title":"Phytother Res"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3389\/fphar.2019.01461","volume":"10","author":"Zhang C.","year":"2020","unstructured":"Zhang C.; Sheng J.; Li G.; Effects of berberine and its derivatives on cancer: A systems pharmacology review. Front Pharmacol 2020,10,1461","journal-title":"Front Pharmacol"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.bbrc.2014.06.039","volume":"450","author":"Zhang L.Y.","year":"2014","unstructured":"Zhang L.Y.; Wu Y.L.; Gao X.H.; Guo F.; Mitochondrial protein cyclophilin-D-mediated programmed necrosis attributes to berberine-induced cytotoxicity in cultured prostate cancer cells. Biochem Biophys Res Commun 2014,450(1),697-703","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.cellsig.2013.01.014","volume":"25","author":"Kang D.","year":"2013","unstructured":"Kang D.; Park W.; Lee S.; Kim J.H.; Song J.J.; Crosstalk from survival to necrotic death coexists in DU-145 cells by curcumin treatment. Cell Signal 2013,25(5),1288-1300","journal-title":"Cell Signal"},{"key":"ref=232","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020460","volume":"9","author":"Fontana F.","year":"2020","unstructured":"Fontana F.; Raimondi M.; Marzagalli M.; Di Domizio A.; Limonta P.; Natural compounds in prostate cancer prevention and treatment: Mechanisms of action and molecular targets. Cells 2020,9(2)","journal-title":"Cells"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1476-5381.2012.02002.x","volume":"167","author":"Stefanska B.","year":"2012","unstructured":"Stefanska B.; Karlic H.; Varga F.; Fabianowska-Majewska K.; Haslberger A.; Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer prevention. Br J Pharmacol 2012,167(2),279-297","journal-title":"Br J Pharmacol"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13148-010-0011-5","volume":"1","author":"Meeran S.M.","year":"2010","unstructured":"Meeran S.M.; Ahmed A.; Tollefsbol T.O.; Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clin Epigenetics 2010,1(3-4),101-116","journal-title":"Clin Epigenetics"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fgene.2019.00514","volume":"10","author":"Hassan F.U.","year":"2019","unstructured":"Hassan F.U.; Rehman M.S.U.; Khan M.S.; Curcumin as an alternative epigenetic modulator: Mechanism of action and potential effects. Front Genet 2019,10,514","journal-title":"Front Genet"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/medicines6010024","volume":"6","author":"Farhan M.","year":"2019","unstructured":"Farhan M.; Ullah M.F.; Faisal M.; Differential methylation and acetylation as the epigenetic basis of resveratrol\u2019s anticancer activity. Medicines (Basel) 2019,6(1),24","journal-title":"Medicines (Basel)"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"888","DOI":"10.4161\/epi.6.7.16315","volume":"6","author":"Zhang Y.","year":"2011","unstructured":"Zhang Y.; Chen H.; Genistein, an epigenome modifier during cancer prevention. Epigenetics 2011,6(7),888-891","journal-title":"Epigenetics"},{"key":"ref=238","doi-asserted-by":"publisher","DOI":"10.1063\/1.5079943","volume":"3","author":"Martinelli C.","year":"2019","unstructured":"Martinelli C.; Pucci C.; Ciofani G.; Nanostructured carriers as innovative tools for cancer diagnosis and therapy. APL Bioeng 2019,3(1)","journal-title":"APL Bioeng"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.2147\/IJN.S138624","volume":"12","author":"Matea C.T.","year":"2017","unstructured":"Matea C.T.; Mocan T.; Tabaran F.; Quantum dots in imaging, drug delivery and sensor applications. Int J Nanomedicine 2017,12,5421-5431","journal-title":"Int J Nanomedicine"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00330-005-2646-8","volume":"15","author":"Leiner T.","year":"2005","unstructured":"Leiner T.; Gerretsen S.; Botnar R.; Magnetic resonance imaging of atherosclerosis. Eur Radiol 2005,15(6),1087-1099","journal-title":"Eur Radiol"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1517\/17425247.2011.566552","volume":"8","author":"Gubernator J.","year":"2011","unstructured":"Gubernator J.; Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity. Expert Opin Drug Deliv 2011,8(5),565-580","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.bbamcr.2015.09.017","volume":"1863","author":"Kumar B.","year":"2016","unstructured":"Kumar B.; Garcia M.; Murakami J.L.; Chen C.C.; Exosome-mediated microenvironment dysregulation in leukemia. Biochim Biophys Acta 2016,1863(3),464-470","journal-title":"Biochim Biophys Acta"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-3-319-53082-6_6","volume":"Vol.\t1: pp.","author":"Martinelli C.","year":"2017","unstructured":"Martinelli C.; Exosomes: new biomarkers for targeted cancer therapy. Molecular oncology: Underlying mechanisms and translational advancements. Switzerland. Springer Nature AG 2017,Vol.\t1: pp.,129-157","journal-title":"Springer Nature AG"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.canlet.2017.11.002","volume":"413","author":"Chikara S.","year":"2018","unstructured":"Chikara S.; Nagaprashantha L.D.; Singhal J.; Horne D.; Awasthi S.; Singhal S.S.; Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment. Cancer Lett 2018,413,122-134","journal-title":"Cancer Lett"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3389\/fpls.2016.01667","volume":"7","author":"Singh S.","year":"2016","unstructured":"Singh S.; Sharma B.; Kanwar S.S.; Kumar A.; Lead phytochemicals for anticancer drug development. Front Plant Sci 2016,7,1667","journal-title":"Front Plant Sci"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1080\/10408398.2016.1252711","volume":"58","author":"Imran M.","year":"2018","unstructured":"Imran M.; Ullah A.; Saeed F.; Nadeem M.; Arshad M.U.; Suleria H.A.R.; Cucurmin, anticancer,","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.biopha.2017.05.044","volume":"92","author":"Liu Y.","year":"2017","unstructured":"Liu Y.; Tang Z.G.; Lin Y.; Effects of quercetin on proliferation and migration of human glioblastoma U251 cells. Biomed Pharmacother 2017,92,33-38","journal-title":"Biomed Pharmacother"},{"key":"ref=248","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00432-014-1767-3","volume":"141","author":"Bazak R.","year":"2015","unstructured":"Bazak R.; Houri M.; El Achy S.; Kamel S.; Refaat T.; Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol 2015,141(5),769-784","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"6832","DOI":"10.1016\/j.biomaterials.2011.05.064","volume":"32","author":"Huang S.","year":"2011","unstructured":"Huang S.; Li J.; Han L.; Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma. Biomaterials 2011,32(28),6832-6838","journal-title":"Biomaterials"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejpb.2008.08.021","volume":"71","author":"Ulbrich K.","year":"2009","unstructured":"Ulbrich K.; Hekmatara T.; Herbert E.; Kreuter J.; Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). Eur J Pharm Biopharm 2009,71(2),251-256","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/ng1092-93","volume":"2","author":"Friedmann T.","year":"1992","unstructured":"Friedmann T.; A brief history of gene therapy. Nat Genet 1992,2(2),93-98","journal-title":"Nat Genet"},{"key":"ref=252","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3015","volume":"20","author":"Ginn S.L.","year":"2018","unstructured":"Ginn S.L.; Amaya A.K.; Alexander I.E.; Edelstein M.; Abedi M.R.; Gene therapy clinical trials worldwide to 2017: An update. J Gene Med 2018,20(5)","journal-title":"J Gene Med"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1109\/MPUL.2011.942603","volume":"2","author":"Brace C.","year":"2011","unstructured":"Brace C.; Thermal tumor ablation in clinical use. IEEE Pulse 2011,2(5),28-38","journal-title":"IEEE Pulse"},{"key":"ref=254","doi-asserted-by":"publisher","first-page":"12474","DOI":"10.1038\/ncomms12474","volume":"7","author":"Yu K.H.","year":"2016","unstructured":"Yu K.H.; Zhang C.; Berry G.J.; Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features. Nat Commun 2016,7(1),12474","journal-title":"Nat Commun"},{"key":"ref=255","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1001\/jamaoncol.2016.2631","volume":"2","author":"Aerts H.J.","year":"2016","unstructured":"Aerts H.J.; The potential of radiomic-based phenotyping in precision medicine: a review. JAMA Oncol 2016,2(12),1636-1642","journal-title":"JAMA Oncol"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1200\/JCO.2007.14.3065","volume":"26","author":"Frangioni J.V.","year":"2008","unstructured":"Frangioni J.V.; New technologies for human cancer imaging. J Clin Oncol 2008,26(24),4012-4021","journal-title":"J Clin Oncol"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/annonc\/mdv184","volume":"26","author":"Heuckmann J.M.","year":"2015","unstructured":"Heuckmann J.M.; Thomas R.K.; A new generation of cancer genome diagnostics for routine clinical use: overcoming the roadblocks to personalized cancer medicine. Ann Oncol 2015,26(9),1830-1837","journal-title":"Ann Oncol"},{"key":"ref=258","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13073-015-0203-x","volume":"7","author":"Gagan J.","year":"2015","unstructured":"Gagan J.; Van Allen E.M.; Next-generation sequencing to guide cancer therapy. Genome Med 2015,7(1),80","journal-title":"Genome Med"},{"key":"ref=259","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.clinthera.2016.03.026","volume":"38","author":"Zugazagoitia J.","year":"2016","unstructured":"Zugazagoitia J.; Guedes C.; Ponce S.; Ferrer I.; Molina-Pinelo S.; Paz-Ares L.; Current challenges in cancer treatment. Clin Ther 2016,38(7),1551-1566","journal-title":"Clin Ther"},{"key":"ref=260","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.ctrv.2014.07.002","volume":"40","author":"Arnedos M.","year":"2014","unstructured":"Arnedos M.; Soria J.C.; Andre F.; Tursz T.; Personalized treatments of cancer patients: a reality in daily practice, a costly dream or a shared vision of the future from the oncology community? Cancer Treat Rev 2014,40(10),1192-1198","journal-title":"Cancer Treat Rev"},{"key":"ref=261","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1200\/EDBK_280571","volume":"40","author":"McKean W.B.","year":"2020","unstructured":"McKean W.B.; Moser J.C.; Rimm D.; Hu-Lieskovan S.; Biomarkers in precision cancer immunotherapy: Promise and challenges. Am Soc Clin Oncol Educ Book 2020,40,e275-e291","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref=262","doi-asserted-by":"publisher","author":"Agrawal L.","unstructured":"Agrawal L.; Engel K.B.; Greytak S.R.; Moore H.M.;  In: Seminars in cancer biology. Academic Press 2018; 52: pp. 26-38.","DOI":"10.1016\/j.semcancer.2017.12.008"},{"key":"ref=263","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/08830185.2015.1015888","volume":"34","author":"Chiriva-Internati M.","year":"2015","unstructured":"Chiriva-Internati M.; Bot A.; A new era in cancer immunotherapy: discovering novel targets and reprogramming the immune system. Int Rev Immunol 2015,34(2),101-103","journal-title":"Int Rev Immunol"},{"key":"ref=264","doi-asserted-by":"publisher","first-page":"339","DOI":"10.15171\/apb.2017.041","volume":"7","author":"Mansoori B.","year":"2017","unstructured":"Mansoori B.; Mohammadi A.; Davudian S.; Shirjang S.; Baradaran B.; The different mechanisms of cancer drug resistance: a brief review. Adv Pharm Bull 2017,7(3),339-348","journal-title":"Adv Pharm Bull"},{"key":"ref=265","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.blre.2005.08.003","volume":"20","author":"Li Z.W.","year":"2006","unstructured":"Li Z.W.; Dalton W.S.; Tumor microenvironment and drug resistance in hematologic malignancies. Blood Rev 2006,20(6),333-342","journal-title":"Blood Rev"},{"key":"ref=266","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.neo.2018.01.001","volume":"20","author":"Das C.K.","year":"2018","unstructured":"Das C.K.; Linder B.; Bonn F.; BAG3 overexpression and cytoprotective autophagy mediate apoptosis resistance in chemoresistant breast cancer cells. Neoplasia 2018,20(3),263-279","journal-title":"Neoplasia"},{"key":"ref=267","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1039\/c1np00008j","volume":"28","author":"Kharwar R.N.","year":"2011","unstructured":"Kharwar R.N.; Mishra A.; Gond S.K.; Stierle A.; Stierle D.; Anticancer compounds derived from fungal endophytes: their importance and future challenges. Nat Prod Rep 2011,28(7),1208-1228","journal-title":"Nat Prod Rep"},{"key":"ref=268","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00253-012-4128-7","volume":"95","author":"Chandra S.","year":"2012","unstructured":"Chandra S.; Endophytic fungi: novel sources of anticancer lead molecules. Appl Microbiol Biotechnol 2012,95(1),47-59","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=269","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1039\/C3NP70111E","volume":"31","author":"Abdelmohsen U.R.","year":"2014","unstructured":"Abdelmohsen U.R.; Bayer K.; Hentschel U.; Diversity, abundance and natural products of marine sponge-associated actinomycetes. Nat Prod Rep 2014,31(3),381-399","journal-title":"Nat Prod Rep"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"7559","DOI":"10.1039\/c1cc11574j","volume":"47","author":"Crawford J.M.","year":"2011","unstructured":"Crawford J.M.; Clardy J.; Bacterial symbionts and natural products. Chem Commun (Camb) 2011,47(27),7559-7566","journal-title":"Chem Commun (Camb)"},{"key":"ref=271","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/ja.2013.77","volume":"67","author":"Ramadhar T.R.","year":"2014","unstructured":"Ramadhar T.R.; Beemelmanns C.; Currie C.R.; Clardy J.; Bacterial symbionts in agricultural systems provide a strategic source for antibiotic discovery. J Antibiot (Tokyo) 2014,67(1),53-58","journal-title":"J Antibiot (Tokyo)"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10295-013-1389-9","volume":"41","author":"Bachmann B.O.","year":"2014","unstructured":"Bachmann B.O.; Van Lanen S.G.; Baltz R.H.; Microbial genome mining for accelerated natural products discovery: is a renaissance in the making? J Ind Microbiol Biotechnol 2014,41(2),175-184","journal-title":"J Ind Microbiol Biotechnol"},{"key":"ref=273","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1039\/b817078a","volume":"26","author":"Brady S.F.","year":"2009","unstructured":"Brady S.F.; Simmons L.; Kim J.H.; Schmidt E.W.; Metagenomic approaches to natural products from free-living and symbiotic organisms. Nat Prod Rep 2009,26(11),1488-1503","journal-title":"Nat Prod Rep"},{"key":"ref=274","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-407678-5.00001-5","volume":"83","author":"Leis B.","year":"2013","unstructured":"Leis B.; Angelov A.; Liebl W.; Screening and expression of genes from metagenomes. Adv Appl Microbiol 2013,83,1-68","journal-title":"Adv Appl Microbiol"},{"key":"ref=275","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mib.2014.05.021","volume":"19","author":"Charlop-Powers Z.","year":"2014","unstructured":"Charlop-Powers Z.; Milshteyn A.; Brady S.F.; Metagenomic small molecule discovery methods. Curr Opin Microbiol 2014,19,70-75","journal-title":"Curr Opin Microbiol"},{"key":"ref=276","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/md8040835","volume":"8","author":"Potts B.C.","year":"2010","unstructured":"Potts B.C.; Lam K.S.; Generating a generation of proteasome inhibitors: from microbial fermentation to total synthesis of salinosporamide a (marizomib) and other salinosporamides. Mar Drugs 2010,8(4),835-880","journal-title":"Mar Drugs"},{"key":"ref=277","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1021\/np100601w","volume":"74","author":"Andrianasolo E.H.","year":"2011","unstructured":"Andrianasolo E.H.; Haramaty L.; McPhail K.L.; Bathymodiolamides A and B, ceramide derivatives from a deep-sea hydrothermal vent invertebrate mussel, Bathymodiolus thermophilus. J Nat Prod 2011,74(4),842-846","journal-title":"J Nat Prod"},{"key":"ref=278","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1080\/09593331003663328","volume":"31","author":"Margesin R.","year":"2010","unstructured":"Margesin R.; Feller G.; Biotechnological applications of psychrophiles. Environ Technol 2010,31(8-9),835-844","journal-title":"Environ Technol"},{"key":"ref=279","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1021\/np200414c","volume":"75","author":"Stierle A.A.","year":"2012","unstructured":"Stierle A.A.; Stierle D.B.; Girtsman T.; Caspase-1 inhibitors from an extremophilic fungus that target specific leukemia cell lines. J Nat Prod 2012,75(3),344-350","journal-title":"J Nat Prod"},{"key":"ref=280","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2011.621940","author":"King GF","unstructured":"King GF;  Venoms as a platform for human drugs: translating toxins into therapeutics . Expert Opin Biol Ther 2011; 11(11): 1469-84.","journal-title":"Venoms as a platform for human drugs: translating toxins into therapeutics"}],"container-title":["Current Drug Discovery Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570163819666220331095744","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/202888\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570163819666220331095744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T08:10:11Z","timestamp":1661069411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/202888\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":280,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570163819666220331095744","relation":{},"ISSN":["1570-1638"],"issn-type":[{"value":"1570-1638","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-09-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e310322202888"}}